Maravai is a holding company. Through its subsidiaries, Co. operates as a life sciences company that provides products to enable the development of drug, therapies, diagnostics, vaccines, and support research on human diseases. Co. operates in two segments: Nucleic Acid Production, which includes messenger ribonucleic acid, long and short oligonucleotides, its CleanCap® capping technology and oligonucleotide building blocks; and Biologics Safety Testing, which sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. We show 16 historical shares outstanding datapoints in our coverage of MRVI's shares outstanding history.
Understanding the changing numbers of MRVI shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like MRVI versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching MRVI by allowing them to research MRVI shares outstanding history
as well as any other stock in our coverage universe. |
Free MRVI Email Alerts:
Video: Shares Outstanding Importance
